Effects of Huanglian Jiedu Decoction on Cognitive Function in Mice with Alzheimer’s Disease Induced by Porphyromonas gingivalis Infection
刊名 Medicinal Plant
作者 Linhao LIU, Mengjia LI, Mingfen LI, Yue ZHAO, Kunyan ZOU, Yifei CHEN*
作者单位 College of Pharmacy, Guilin Medical University, Guilin 541199, China; Guangxi Key Laboratory of Drug Discovery and Optimization, Guilin 541199, China; Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Drug Property Evaluation, Guilin Medical University, Guilin 541199, China
DOI DOI:10.19600/j.cnki.issn2152-3924.2026.010.014
年份 2026
刊期 1
页码 61-64
关键词 Huanglian Jiedu Decoction (HLJDD), Porphyromonas gingivalis, Alzheimer’s disease (AD), Novel object recognition, Neuroinflammation
摘要 [Objectives] To investigate the ameliorative effects of Huanglian Jiedu Decoction (HLJDD) on cognitive function impairment in an Alzheimer’s disease (AD) mouse model induced by Porphyromonas gingivalis infection. [Methods] Thirty-six male C57BL/6 mice were randomly assigned to six groups: control group, model group, low-dose HLJDD group, medium-dose HLJDD group, high-dose HLJDD group, and positive drug group (treated with moxifloxacin). With the exception of the control group, all groups underwent an 8-week P. gingivalis chronic infection model induced via oral administration. Subsequently, each treatment group received corresponding doses of HLJDD (2.5, 5, and 10 mg/g) or moxifloxacin for 8 week intervention. The novel object recognition test was employed to evaluate the non-spatial memory abilities of mice, and the novel object exploration preference index was calculated to assess cognitive function. [Results] Compared to the control group, the novel object exploration preference index of mice in the model group was significantly reduced (P<0.01), indicating that P. gingivalis infection effectively induced cognitive impairment. Relative to the model group, mice treated with medium and high doses of HLJDD exhibited a significant, dose-dependent increase in the novel object exploration preference index, whereas the low-dose group showed no significant improvement. Additionally, the positive drug moxifloxacin demonstrated a significant neuroprotective effect on cognition. [Conclusions] HLJDD effectively improves cognitive function impairment in AD model mice induced by P. gingivalis infection, offering novel experimental evidence supporting the heat-clearing and detoxification approach as well as the therapeutic potential of traditional Chinese medicine (TCM) compounds in the intervention of AD.